Form 4 for CRL Charles River Laboratories
Accepted 2026-08-20 16:33:49 ET · period of report 2026-08-19 · accession 0001100682-26-000136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-20 16:33 | 2026-08-19 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | M - OptEx | $194.12 | +2,039 | 6,846 | +42% | +$395.8K |
| DT | 2026-08-20 16:33 | 2026-08-19 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | S - Sale+OE | $294.12 | -2,039 | 4,807 | -30% | -$599.7K |
| DT | 2026-08-20 16:33 | 2026-08-19 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | M - OptEx | $0.00 | -2,039 | 2,039 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | M | A | 2,039 | $194.12 | 6,846 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-19 | S | D | 2,039 | $294.12 | 4,807 | D | — | — | (F1) This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. |
| 3 | Derivative | Stock Options (Right to Buy) | 2026-08-19 | M | D | 2,039 | $0.00 | 2,039 | D | $194.12 · 2024-05-26 to 2033-05-26 | 2,039 Common Stock |